{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:16:55Z","timestamp":1792858615752,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Saitama Prefectural University Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Long-term comparison of COVID-19 epidemic waves is challenging because surveillance systems and reporting practices change over time. In Japan, official reporting shifted repeatedly between January 2020 and December 2025, from comprehensive nationwide notification to restricted reporting and sentinel-based surveillance. Using publicly available national data on reported cases and deaths, we characterized 13 epidemic waves while explicitly accounting for reporting transitions. We described weekly incidence and mortality rates per 100,000 population using population-based indicators to enable comparison across heterogeneous surveillance frameworks. Early waves showed very high observed case fatality ratios. Observed case fatality ratios declined markedly in subsequent waves, although estimates varied with reporting criteria and adjustments for reporting limitations, including periods when mild cases were excluded. Death counts were available only through week 18 of 2023, precluding evaluation of population-based mortality and observed case fatality ratios after the transition to sentinel-based surveillance. This transparent bridging framework enables longitudinal, comparability-oriented description of 13 epidemic waves in Japan across the 2023 surveillance transition. These findings should be interpreted as descriptive patterns observed under evolving surveillance contexts, and causal attribution is beyond the scope of this study.<\/jats:p>","DOI":"10.1038\/s41598-026-51317-0","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:43:07Z","timestamp":1779356587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal characterization of COVID-19 across a surveillance transition in Japan: thirteen epidemic waves, 2020\u20132025"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-7961","authenticated-orcid":false,"given":"Chihiro","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Nakaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Oki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosikazu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"51317_CR1","unstructured":"Ministry of Health, Labour and Welfare. Regarding the First Case of Pneumonia Associated with the Novel Coronavirus (COVID-19) \u2013 Press Release. (in Japanese) [cited 2026 Jan 16]. (2020). https:\/\/www.mhlw.go.jp\/stf\/newpage_08906.html"},{"key":"51317_CR2","unstructured":"Ministry of Justice. Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control Law). [cited 2026 Jan 16]. https:\/\/www.japaneselawtranslation.go.jp\/en\/laws\/view\/2830"},{"key":"51317_CR3","unstructured":"Japan Institute for Health Security. Field Briefing: Diamond Princess COVID-19 Cases. [cited 2026 Jan 16]. (2020). https:\/\/id-info.jihs.go.jp\/niid\/en\/2019-ncov-e\/9407-covid-dp-fe-01.html"},{"issue":"2","key":"51317_CR4","doi-asserted-by":"publisher","first-page":"e18821","DOI":"10.2196\/18821","volume":"6","author":"Y Yamahata","year":"2020","unstructured":"Yamahata, Y. & Shibata, A. Preparation for Quarantine on the Cruise Ship Diamond Princess in Japan due to COVID-19. JMIR Public. Health Surveill. 6(2), e18821. https:\/\/doi.org\/10.2196\/18821 (2020).","journal-title":"JMIR Public. Health Surveill"},{"key":"51317_CR5","unstructured":"Ministry of Justice. Act on Special Measures Against Novel Influenza Japanese Law translation 2023; Act No. 14 of 2023. [cited 2026 Jan 16]. https:\/\/www.japaneselawtranslation.go.jp\/en\/laws\/view\/4938"},{"key":"51317_CR6","unstructured":"Ministry of Health, Labour and Welfare (Japan). Revision of universal case notification toward a new phase of COVID-19 response [administrative notice]. Sep 12 (last revised 2023 Jan 11). (in Japanese) [cited 2026 Jan 16]. (2022). https:\/\/www.mhlw.go.jp\/content\/001038933.pdf"},{"key":"51317_CR7","unstructured":"World Health Organization. Statement on the fifteenth meeting of the IHR. Emergency Committee on the COVID-19 pandemic. 2023. [cited 2026 Jan 16]. (2005). https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-%282005%29-emergency-committee-regarding-the-coronavirus-disease-%28covid-19%29-pandemic"},{"key":"51317_CR8","unstructured":"Ministry of Health, Labour and Welfare. Response to COVID 19 (Novel Coronavirus) after the classification change. [cited 2026 Jan 16]. https:\/\/www.mhlw.go.jp\/stf\/covid-19\/kenkou-iryousoudan_00006.html"},{"key":"51317_CR9","unstructured":"Ministry of Health, Labour and Welfare. Visualizing the data: information on COVID-19 infections. [cited 2026 Jan 16]. https:\/\/covid19.mhlw.go.jp\/en\/"},{"key":"51317_CR10","unstructured":"Japan Institute for Health Security. Infectious Disease Weekly Reports. [cited 2026 Jan 16]. https:\/\/id-info.jihs.go.jp\/surveillance\/idwr\/en\/rapid\/index.html"},{"key":"51317_CR11","unstructured":"Japan Institute for Health Security. SARS-CoV-2 variants (past data). (in Japanese) [cited 2026 Jan 16]. https:\/\/id-info.jihs.go.jp\/diseases\/sa\/covid-19\/190\/flu2-1-2.html"},{"key":"51317_CR12","unstructured":"Ministry of Health, Labour and Welfare. Number of COVID-19 vaccine doses during the special temporary vaccination period. [cited 2026 Jan 16]. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/syukeihou_00002.html"},{"issue":"1","key":"51317_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1186\/s12879-021-06449-1","volume":"21","author":"SXW Gwee","year":"2021","unstructured":"Gwee, S. X. W., Chua, P. E. Y., Wang, M. X. & Pang, J. Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study. BMC Infect. Dis. 21(1), 799. https:\/\/doi.org\/10.1186\/s12879-021-06449-1 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"51317_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3201\/eid2607.200574","volume":"26","author":"C Lin","year":"2020","unstructured":"Lin, C. et al. Policy Decisions and Use of Information Technology to Fight COVID-19, Taiwan. Emerg. Infect. Dis. 26(7), 1506\u20131512. https:\/\/doi.org\/10.3201\/eid2607.200574 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"51317_CR15","doi-asserted-by":"publisher","DOI":"10.35772\/ghmo.2024.01007","author":"Y Horie","year":"2024","unstructured":"Horie, Y. et al. Validity of vaccination information in the COVID-19 surveillance system in Japan: Implications for developing efficient and highly valid data collection systems in future pandemics. GHM Open. https:\/\/doi.org\/10.35772\/ghmo.2024.01007 (2024).","journal-title":"GHM Open."},{"issue":"7","key":"51317_CR16","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3201\/eid3007.230968","volume":"30","author":"T Ogata","year":"2024","unstructured":"Ogata, T., Tanaka, H., Kon, A., Sakaibori, N. & Tanaka, E. Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2-Dominant Period, Japan. Emerg. Infect. Dis. 30(7), 1430\u20131433. https:\/\/doi.org\/10.3201\/eid3007.230968 (2024).","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"51317_CR17","doi-asserted-by":"publisher","first-page":"26996","DOI":"10.1038\/s41598-024-78583-0","volume":"14","author":"S Nagata","year":"2024","unstructured":"Nagata, S., Takahashi, Y., Adachi, H. M., Johnson, G. D. & Nakaya, T. Local effects of non-pharmaceutical interventions on mitigation of COVID-19 spread through decreased human mobilities in Japan: a prefecture-level mediation analysis. Sci. Rep. 14(1), 26996. https:\/\/doi.org\/10.1038\/s41598-024-78583-0 (2024).","journal-title":"Sci. Rep."},{"key":"51317_CR18","doi-asserted-by":"publisher","first-page":"18053","DOI":"10.1038\/s41598-020-75033-5","volume":"10","author":"T Yabe","year":"2020","unstructured":"Yabe, T. et al. Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic. Sci. Rep. 10, 18053. https:\/\/doi.org\/10.1038\/s41598-020-75033-5 (2020).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51317-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:27:13Z","timestamp":1784849233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51317"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51317-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All estimates were intended to improve continuity and comparability of long-term epidemic trends rather than to provide precise estimates of the true number of SARS-CoV-2 infections. As all data were aggregated and publicly available, ethical approval was not required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23164"}}